ancistrocladidine has been researched along with Leishmaniasis in 1 studies
*Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bringmann, G; Faber, JH; Gulder, T; Kajahn, I; Moll, H; Pedersen, SE; Ponte-Sucre, A; Schultheis, M | 1 |
1 other study(ies) available for ancistrocladidine and Leishmaniasis
Article | Year |
---|---|
Activities of naphthylisoquinoline alkaloids and synthetic analogs against Leishmania major.
Topics: Alkaloids; Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Cells, Cultured; Cytokines; Dendritic Cells; Dose-Response Relationship, Drug; Fibroblasts; Isoquinolines; Leishmania major; Leishmaniasis; Macrophages; Mice; Mice, Inbred BALB C; Molecular Structure; NIH 3T3 Cells; Nitric Oxide; Parasitic Sensitivity Tests | 2007 |